Patients presenting to the Esophageal Center of Northwestern for evaluation of dysphagia between November, 2012 and April, 2016 that completed HRM and FLIP during upper endoscopy were prospectively included. Upper endoscopy was completed using sedation with midazolam (2 - 15 mg) and fentanyl (0 - 300 mcg); propofol (in addition to midazolam and fentanyl) was used with anesthesiologist assistance at the discretion of the performing endoscopist in some cases. Patients with previous upper gastrointestinal surgery, significant medical co-morbidities, eosinophilic esophagitis, severe reflux esophagitis (LA-classification C or D), or large hiatal hernia were excluded. Patients were often identified by referral for manometry, thus FLIP was commonly included with the endoscopic evaluation if an esophageal motility disorder was suspected. Enrollment of achalasia patients was prioritized, but limited to 70 patients: 49 of the achalasia patients were previously described.(11 (link)) We intentionally included an excess of achalasia patients to evaluate the diagnostic effectiveness of FLIP topography for this important esophageal motility disorder. Additional clinical evaluation (e.g. barium esophagram) were obtained and management decisions made at the discretion of the primary treating gastroenterologist. The study protocol was approved by the Northwestern University Institutional Review Board.
>
Chemicals & Drugs
>
Organic Chemical
>
Propofol
Propofol
Propofol is a short-acting, intravenous general anesthetic agent used for the induction and maintenance of anesthesia, as well as for sedation.
It is commonly used in surgical procedures, critical care settings, and for the management of status epilepticus.
Propofol has a rapid onset of action and a short duration of effect, making it a popular choice for anesthesia and sedation.
Researchers can streamline their Propofol studies by utilizing PubCompare.ai's AI-driven protocol comparison tool, which helps identify the most reproducible and accurate approaches from the literature, preprints, and patents.
This powerful tool provides AI-powered insights to optimize Propofol research and ensure the highest levels of accuracy and reproducibility.
It is commonly used in surgical procedures, critical care settings, and for the management of status epilepticus.
Propofol has a rapid onset of action and a short duration of effect, making it a popular choice for anesthesia and sedation.
Researchers can streamline their Propofol studies by utilizing PubCompare.ai's AI-driven protocol comparison tool, which helps identify the most reproducible and accurate approaches from the literature, preprints, and patents.
This powerful tool provides AI-powered insights to optimize Propofol research and ensure the highest levels of accuracy and reproducibility.
Most cited protocols related to «Propofol»
Anesthesiologist
Barium
Deglutition Disorders
Diagnosis
Endoscopy
Endoscopy, Gastrointestinal
Eosinophilic Esophagitis
Esophageal Achalasia
Ethics Committees, Research
Fentanyl
Gastroenterologist
Hiatal Hernia
Manometry
Midazolam
Motility Disorders, Esophageal
Operative Surgical Procedures
Patients
Peptic Esophagitis
Propofol
Sedatives
Upper Gastrointestinal Tract
We sequenced the venom-gland transcriptome of a single animal from Florida (Wakulla County): an adult female weighing 393 g with a snout-to-vent length of 792 mm and a total length of 844 mm. To stimulate transcription in the venom glands, we anesthetized the snake by propofol injection (10 mg/kg) and extracted venom by electrostimulation under anesthesia [86 (link)]. After venom extraction, the animal was allowed to recover for four days while transcription levels reached their maxima [87 (link)]. The snake was euthanized by injection of sodium pentobarbitol (100 mg/kg), and its venom glands were subsequently removed. The above techniques were approved by the Florida State University Institutional Animal Care and Use Committee (IACUC) under protocol #0924.
Sequencing and nonnormalized cDNA library preparation were performed by the HudsonAlpha Institute for Biotechnology Genomic Services Laboratory (http://www.hudsonalpha.org/gsl/ ). Transcriptome sequencing was performed essentially as described by Mortazavi et al. [88 (link)] in a modification of the standard Illumina methods described in detail in Bentley et al. [89 (link)]. Total RNA was reduced to poly-A+ RNA with oligo-dT beads. Two rounds of poly-A+ selection were performed. The purified mRNA was then subjected to a mild heat fragmentation followed by random priming for first-strand synthesis. Standard second-strand synthesis was followed by standard library preparation with the double-stranded cDNA as input material. This approach is similar to that of Illumina’s TruSeq RNA-seq library preparation kit. Sequencing was performed in one lane on the Illumina HiSeq 2000 with 100-base-pair paired-end reads.
Sequencing and nonnormalized cDNA library preparation were performed by the HudsonAlpha Institute for Biotechnology Genomic Services Laboratory (
Full text: Click here
Anabolism
Anesthesia
Animals
Base Pairing
cDNA Library
DNA, Complementary
Genome
Institutional Animal Care and Use Committees
oligo (dT)
Poly A
Propofol
RNA, Messenger
RNA, Polyadenylated
RNA-Seq
Snakes
Sodium
Standard Preparations
Transcription, Genetic
Transcriptome
Venoms
Woman
Acute Coronary Syndrome
Angina Pectoris
Benzodiazepines
Cardiac Arrest
Cardiac Arrhythmia
Care, Comfort
Catheterizations, Cardiac
Catheters
Chest
Cognitive Training
Comatose
Consciousness
Echocardiography
Electric Countershock
Esophagus
Gastric Lavage
Glycemic Control
Implantable Defibrillator
Injuries
Inotropism
Insulin
Intracranial Hemorrhage
Intravenous Infusion
Left Bundle-Branch Block
Neurologic Examination
Operative Surgical Procedures
Patients
physiology
Propofol
Pulmonary Artery
Rectum
Saline Solution
Sedatives
Seizures
Urinary Bladder
Urine
Vasoconstrictor Agents
Performance of the EPC was tested in awake behaving monkeys. Following initial training monkeys were implanted with a head holder, eye coil, and recording chambers above V1 under general anesthesia and sterile conditions. For the anesthesia animals were initially sedated with a 0.1 ml/kg ketamine intra-muscular injection (100 mg/ml). Thereafter, bolus injections of propofol were administered intra-venously to allow for tracheal intubation (0.05–0.1 ml). Prior to surgery a bolus injection of dexamethosone sodium phosphate was administered i.v. (0.33 mg/kg). During surgery anesthesia was maintained by gaseous anaesthetic (1–3% sevoflurane) combined with continuous i.v. application of an opioid analgesic (Alfentanil, 156 μg/kg/h). The animal's rectal temperature, heart rate, blood oxygenation and expired CO2 were continuously monitored during surgery. Immediately after surgery (and during the following 3–5 days) the animals were given antibiotics (Cephorex 0.5 ml/kg or Synolux 0.25 ml/kg) and analgesics (Metacam 0.1 ml/kg).
Following surgery the recording chambers were regularly cleaned under sterile conditions and 5-fluoro-uracil treatment was performed three times per week (Spinks et al., 2003 (link)). Despite 5-fluoro-uracil treatment it was necessary to perform dura scrapes every 6–8 weeks for the removal of fibrous scar tissue above the craniotomy.
All animal and surgical procedures were in accordance with the European Communities Council Directive 1986 (86/609/EEC), the National Institutes of Health guidelines for care and use of animals for experimental procedures, the Society for Neurosciences Policies on the Use of Animals and Humans in Neuroscience Research, and the UK Animals Scientific Procedures Act.
Following surgery the recording chambers were regularly cleaned under sterile conditions and 5-fluoro-uracil treatment was performed three times per week (Spinks et al., 2003 (link)). Despite 5-fluoro-uracil treatment it was necessary to perform dura scrapes every 6–8 weeks for the removal of fibrous scar tissue above the craniotomy.
All animal and surgical procedures were in accordance with the European Communities Council Directive 1986 (86/609/EEC), the National Institutes of Health guidelines for care and use of animals for experimental procedures, the Society for Neurosciences Policies on the Use of Animals and Humans in Neuroscience Research, and the UK Animals Scientific Procedures Act.
Full text: Click here
Alfentanil
Analgesics
Analgesics, Opioid
Anesthesia
Anesthetic Gases
Animals
Antibiotics, Antitubercular
BLOOD
Cell Respiration
Cicatrix
Craniotomy
Dura Mater
Fibrosis
Fluorouracil
General Anesthesia
Head
Homo sapiens
Intramuscular Injection
Intubation, Intratracheal
Ketamine
Monkeys
Operative Surgical Procedures
Propofol
Rate, Heart
Rectum
Sevoflurane
sodium phosphate
Sterility, Reproductive
Tissues
Electroencephalography
Epistropheus
EPOCH protocol
General Anesthesia
Patients
Propofol
Sevoflurane
Most recents protocols related to «Propofol»
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Anesthesia
Animals
Cells
Copper
Disinfection
Fascia
Gelatins
Glutaral
Hemostasis
Ilium
Infection
Injuries
Laminectomy
Muscle Tissue
Needles
Normal Saline
Operative Surgical Procedures
Penicillins
Phosphotungstic Acid
Pigs
Porifera
Povidone Iodine
Propofol
Punctures, Lumbar
Skin
Spinal Canal
Spinal Cord
Telazol
Transmission Electron Microscopy
TSG101 protein, human
Vertebra
Western Blot
Wounds
Xylazine
This is a secondary analysis of the prospective, randomised, double-blind placebo-controlled NEUPRODEX trial that took place between July 2014 and July 20188 . The primary outcome of this study was the postoperative incidence of delirium as measured by CAM-ICU (Confusion Assessment Method for the intensive care unit) or CAM (Confusion Assessment Method for normal wards) twice daily until the fifth postoperative day. The trial was approved by the regional ethics committee of Berlin, Germany (Landesamt für Gesundheit und Soziales, Approval Number 13/0491-EK 11) and was registered in the EU clinical trials register (2013–000,823-15) and the American National Institute of Health register (NCT02096068 on 26/03/2014). Inclusion and exclusion criteria are stated in our recent publication about the primary outcome as well as randomization process8 . After written informed consent, the elderly patients were randomly assigned to dexmedetomidine or placebo group. The requirement for inclusion in this secondary analysis was the existence of a complete series of measurements of perioperative AChE and BChE activity. Patients with incomplete values were not included.
All patients received general anaesthesia induced with propofol and were maintained with either propofol or sevoflorane. All measures and procedures were performed in accordance with relevant guidelines and regulations. Our hospital pharmacy prepared syringes with dexmedetomidine or placebo, blinding both physicians and investigators. Starting ten minutes after induction, patients received either 0.7 µg/kg adjusted body weight (ABW)/h continuously or an equivalent volume of normal saline. The dose was reduced to 0.4 µg/kg ABW/h 30 min before the end of surgery. After arrival at the ICU, the dose was further reduced, but could be increased again to achieve a RASS score between 0 and − 1. During surgery, bradycardia as a side effect of dexmedetomidine was treated either by administration of orciprenaline or dose reduction of the syringe driver, containing either dexmedetomidine or placebo.
For analysis, we classified patients according to anticholinergic burden of their permanent medication taken at home. The Anticholinergic Drug Scale (ADS) developed by Carnahan and his colleagues59 (link) with originally four items was dichotomized into 0 (no preoperative anticholinergic burden) and 1 (level of anticholinergic burden ≥ 1) to evaluate whether possible alterations of cholinesterase activity by these medications were balanced between groups.
All patients received general anaesthesia induced with propofol and were maintained with either propofol or sevoflorane. All measures and procedures were performed in accordance with relevant guidelines and regulations. Our hospital pharmacy prepared syringes with dexmedetomidine or placebo, blinding both physicians and investigators. Starting ten minutes after induction, patients received either 0.7 µg/kg adjusted body weight (ABW)/h continuously or an equivalent volume of normal saline. The dose was reduced to 0.4 µg/kg ABW/h 30 min before the end of surgery. After arrival at the ICU, the dose was further reduced, but could be increased again to achieve a RASS score between 0 and − 1. During surgery, bradycardia as a side effect of dexmedetomidine was treated either by administration of orciprenaline or dose reduction of the syringe driver, containing either dexmedetomidine or placebo.
For analysis, we classified patients according to anticholinergic burden of their permanent medication taken at home. The Anticholinergic Drug Scale (ADS) developed by Carnahan and his colleagues59 (link) with originally four items was dichotomized into 0 (no preoperative anticholinergic burden) and 1 (level of anticholinergic burden ≥ 1) to evaluate whether possible alterations of cholinesterase activity by these medications were balanced between groups.
Full text: Click here
Aged
Anticholinergic Agents
Body Weight
Cholinesterases
Dexmedetomidine
Drug Tapering
Emergence Delirium
General Anesthesia
Metaproterenol
Normal Saline
Operative Surgical Procedures
Pain
Patients
Pharmaceutical Preparations
Physicians
Placebos
Propofol
ras Oncogene
Regional Ethics Committees
Syringes
Anesthesiologists used neuroleptic sedation for each patient with a combination of ketamine, midazolam, fentanyl and propofol. The surgeon used loupes with a 3.3X magnification and a headlight. The tumour was assessed, measured (Figure 1A ), and marked with standard four millimetre surgical margins for BCC and seven millimeter surgical margins for melanoma in situ (MIS). The width of the excised area was documented. The donor tissue width was estimated and marked (Figure 1B ). The donor lid was then stretched horizontally, ensuring that the secondary defect could undergo direct closure. One drop of topical anesthesia was placed in each eye and the operative site was prepared with controlled use of chlorhexidine to limit the risk of corneal toxicity. The surgeon performed subcutaneous infiltration of the tumor and donor sites using lidocaine 2% with epinephrine 1:100,000; 2 ml or less per eyelid. All tissue was handled with 0.5 mm toothed forceps to preserve its architecture and integrity.
Full text: Click here
Anesthesiologist
Antipsychotic Agents
Chlorhexidine
Cornea
Epinephrine
Eyelids
Fentanyl
Forceps
Ketamine
Lidocaine
Melanoma
Midazolam
Neoplasms
Patients
Propofol
Sedatives
Surgeons
Surgical Margins
Tissue Donors
Tissues
Topical Anesthetics
In Yuan et al study,[29 (link)] patients received standardized general anesthesia and basic analgesic protocol. Intraoperatively, all patients received general anesthesia which was induced by sufentanil 0.5 μg/kg, midazolam 0.04 mg/kg, propofol 1 to 2 mg/kg, and Cisatracurium 2 μg/kg intravenously, followed by continuous intravenous infusion of remifentanil 0.1 to 0.3 μg/(kg·min), propofol 2 to 5 mg/(kg·hr) and inhalation of sevoflurane to maintain anesthesia. Since postoperative day 1, the protocol of oral celecoxib restarted till postoperative 3 weeks when the patients came back to the hospital for taking out the stitches. In Yadeau et al 2016 study,[6 (link)] patients received a standardized anesthetic and multimodal analgesic protocol. In Yadeau et al 2022 study,[28 (link)] patients received a standard intraoperative and postoperative multimodal anesthetic protocol: a spinal-epidural (subarachnoid mepivacaine, 45–60 mg); adductor canal block (ultrasound-guided; 15 cc bupivacaine, 0.25%, with 2 mg preservative-free dexamethasone). For postoperative pain management, patients were scheduled to receive the study medication once daily for 14 days; 4 doses of 1000 mg IV acetaminophen every 6 hours followed by 1000 mg oral acetaminophen every 8 hours; 4 doses of 15 mg IV ketorolac followed by 15 mg meloxicam every 24 hours; and 5 to 10 mg oral oxycodone was given as needed for pain. Patients could have pain medications adjusted as indicated. In Koh et al study,[12 (link)] all patients had a postoperative intravenous patient-controlled anesthesia (PCA) pump that administered 1 mL of a 100-mL mixture containing 2000 mg of fentanyl on demand. In Kim et al study,[27 ] all patients received intravenous PCA encompassing delivery of 1 mL of a 100 mL solution containing 2000 µg of fentanyl postoperatively. In Ho et al study,[26 (link)] patients were routinely offered a single shot spinal anesthesia consisting of an intrathecal dose of bupivacaine 10 to 12.5 mg with fentanyl 10 mg. After surgery, pain treatment consisted of PCA with intravenous injection of morphine. The settings were 1 mg bolus, 5 minutes lockout time, and a maximum hourly limit of 8 mg. All patients were also given acetaminophen 1 g 6 hourly.
Acetaminophen
Analgesics
Anesthesia
Anesthesia, Intravenous
Anesthetics
Bupivacaine
Cardiac Arrest
Celecoxib
cisatracurium
Dexamethasone
Fentanyl
General Anesthesia
Inhalation
Intravenous Infusion
Ketorolac
Management, Pain
Meloxicam
Mepivacaine
Midazolam
Morphine
Multimodal Imaging
Obstetric Delivery
Operative Surgical Procedures
Oxycodone
Pain
Pain, Postoperative
Patients
Pharmaceutical Preparations
Pharmaceutical Preservatives
Propofol
Pulp Canals
Remifentanil
Sevoflurane
Spinal Anesthesia
Subarachnoid Space
Sufentanil
Ultrasonography
The study was approved by the Ethics Committee of Weifang People’s Hospital and registered at http://www.chictr.org.cn (Chinese Clinical Trial Registry, ChiCTR2200057803). The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines. Informed consent was signed by the patients and their families who participated in the study.
Patients proposed for hysteroscopy day surgery under total intravenous anesthesia, aged 18 to 65 years, American Society of Anesthesiologists (ASA) grade I or II were selected. Exclusion criteria were breastfeeding, a history of chronic pain, a history of sedative and analgesic administration or allergy to any of the study drugs, severe hypertension, and diabetes mellitus. Reject criteria were a procedure time of more than 1 hour, discharged the next day, missing follow-up with the electronic questionnaire pushed 24 hours after the procedure. The included patients were randomized into 3 groups: dexamethasone plus saline group (DC group), dexamethasone plus droperidol group (DD group) and dexamethasone plus propofol group (DP group). The DC group was used as the control group and the remaining 2 groups as the intervention group. Random allocation of included patients by an independent researcher using Excel 2016 (Microsoft) with a 1:1:1 allocation. The participating patients, the outcome assessment fellows, were unaware of the group allocation, only the doctor administering the anesthetic was aware of the grouping of patients and all patients were anesthetized by the same anesthetist.
Patients were routinely fasted and no pre operative medication was administered. After the patient entered the operating room, the intravenous channel was established, and the patient’s ECG, SPO2, NIBP, and BIS were monitored. Patients in each group were given dexamethasone 5 mg for anti-inflammatory and antiemetic prophylaxis before induction, and flurbiprofen axetil 50 mg for preemptive analgesia. Induction of anesthesia: remimazolam 6 mg/kg/hours was continuously infused until sleep, and then mivacurium 0.2 mg/kg and alfentanil 20 ug/kg were slowly injected, after 3 minutes of mask ventilation, the laryngeal mask was placed by the anesthesiologist and mechanical ventilation was performed. Anesthesia maintenance: alfentanil 40 ug/kg/hours and remimazolam 1 mg/kg/hour continuous infusion, stop infusion at the end of the operation. BIS value was maintained between 40 and 60, and 0.1 mg/kg of mivacurium was injected intermittently when necessary. After the start of surgery DC group was given 2ml saline, DD group was given droperidol 1 mg, and DP group was given propofol 20 mg. After awakening and extubation, the patient was taken to the postanesthesia care unit (PACU) and assessed for nausea and vomiting. Patients were discharged after meeting discharge criteria as assessed by the Post-anesthetic Discharge Scoring System (PADSS) criteria. An electronic follow-up questionnaire was pushed 24 hours after the operation. Basic information about the patient’s medical history and surgery was obtained through pre operative anesthesia clinic assessment, intraoperative anesthesia monitoring, in the inpatient electronic medical record, and observation notes in the PACU.
Patients proposed for hysteroscopy day surgery under total intravenous anesthesia, aged 18 to 65 years, American Society of Anesthesiologists (ASA) grade I or II were selected. Exclusion criteria were breastfeeding, a history of chronic pain, a history of sedative and analgesic administration or allergy to any of the study drugs, severe hypertension, and diabetes mellitus. Reject criteria were a procedure time of more than 1 hour, discharged the next day, missing follow-up with the electronic questionnaire pushed 24 hours after the procedure. The included patients were randomized into 3 groups: dexamethasone plus saline group (DC group), dexamethasone plus droperidol group (DD group) and dexamethasone plus propofol group (DP group). The DC group was used as the control group and the remaining 2 groups as the intervention group. Random allocation of included patients by an independent researcher using Excel 2016 (Microsoft) with a 1:1:1 allocation. The participating patients, the outcome assessment fellows, were unaware of the group allocation, only the doctor administering the anesthetic was aware of the grouping of patients and all patients were anesthetized by the same anesthetist.
Patients were routinely fasted and no pre operative medication was administered. After the patient entered the operating room, the intravenous channel was established, and the patient’s ECG, SPO2, NIBP, and BIS were monitored. Patients in each group were given dexamethasone 5 mg for anti-inflammatory and antiemetic prophylaxis before induction, and flurbiprofen axetil 50 mg for preemptive analgesia. Induction of anesthesia: remimazolam 6 mg/kg/hours was continuously infused until sleep, and then mivacurium 0.2 mg/kg and alfentanil 20 ug/kg were slowly injected, after 3 minutes of mask ventilation, the laryngeal mask was placed by the anesthesiologist and mechanical ventilation was performed. Anesthesia maintenance: alfentanil 40 ug/kg/hours and remimazolam 1 mg/kg/hour continuous infusion, stop infusion at the end of the operation. BIS value was maintained between 40 and 60, and 0.1 mg/kg of mivacurium was injected intermittently when necessary. After the start of surgery DC group was given 2ml saline, DD group was given droperidol 1 mg, and DP group was given propofol 20 mg. After awakening and extubation, the patient was taken to the postanesthesia care unit (PACU) and assessed for nausea and vomiting. Patients were discharged after meeting discharge criteria as assessed by the Post-anesthetic Discharge Scoring System (PADSS) criteria. An electronic follow-up questionnaire was pushed 24 hours after the operation. Basic information about the patient’s medical history and surgery was obtained through pre operative anesthesia clinic assessment, intraoperative anesthesia monitoring, in the inpatient electronic medical record, and observation notes in the PACU.
Alfentanil
Analgesics
Anesthesia
Anesthesia, Intravenous
Anesthesiologist
Anesthetics
Anesthetist
Anti-Inflammatory Agents
Antiemetics
Chinese
Chronic Pain
Dexamethasone
Diabetes Mellitus
Droperidol
Drug Allergy
Ethics Committees, Clinical
flurbiprofen axetil
High Blood Pressures
Hysteroscopy
Inpatient
Laryngeal Masks
Management, Pain
Mechanical Ventilation
Mivacurium
Nausea
Operative Surgical Procedures
Patient Discharge
Patients
Pharmaceutical Preparations
Physicians
Propofol
remimazolam
Saline Solution
Saturation of Peripheral Oxygen
Sedatives
Sleep
Surgery, Day
Tracheal Extubation
Top products related to «Propofol»
Sourced in United States, Germany, United Kingdom, China, Sao Tome and Principe
Propofol is a sterile, injectable emulsion used as a general anesthetic and sedative agent. It is a colorless to slightly yellow oil-in-water emulsion. Propofol is intended for intravenous administration.
Sourced in Germany, Austria, China, United States, United Kingdom, Belgium, Sweden, Israel
Propofol is a pharmaceutical product used as a general anesthetic and sedative. It is a sterile, nonpyrogenic injectable emulsion that contains the active ingredient propofol and other inactive ingredients. Propofol is administered intravenously and is used to induce and maintain general anesthesia, as well as for sedation in intensive care unit (ICU) settings.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United Kingdom, Italy, China, Sweden, New Zealand, United States
Propofol is a lab equipment product that is used as a general anesthetic and sedative. It is a clear, colorless liquid that is administered intravenously.
Sourced in United Kingdom, Italy, Japan, China, Turkiye
Diprivan is a laboratory equipment product manufactured by AstraZeneca. It is an intravenous anesthetic agent primarily used for the induction and maintenance of general anesthesia. The core function of Diprivan is to provide a controlled and safe administration of anesthesia in clinical settings.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in Germany
Propofol is an intravenous anesthetic agent used in medical procedures. It induces and maintains a state of unconsciousness and suppresses the body's response to surgical stimulation.
Sourced in United States, United Kingdom, Spain, Israel, Belgium, Australia
IsoFlo is a laboratory equipment product offered by Abbott. It is designed for use in clinical and research settings. IsoFlo serves as a tool for analysis and measurement, but a detailed description of its core function cannot be provided while maintaining an unbiased and factual approach.
Sourced in Germany, France
Propofol-Lipuro is an intravenous anesthetic agent manufactured by B. Braun. It is used to induce and maintain general anesthesia. The product contains the active ingredient propofol emulsified in a lipid solution.
Sourced in United States
Propofol is a short-acting intravenous anesthetic agent used for the induction and maintenance of general anesthesia. It is a lipid-soluble, clear, colorless, and odorless liquid.
More about "Propofol"
Propofol, also known as 2,6-diisopropylphenol, is a widely used intravenous (IV) general anesthetic agent.
It is commonly employed for the induction and maintenance of anesthesia, as well as for sedation in critical care settings and for the management of status epilepticus.
Propofol is prized for its rapid onset of action and short duration of effect, making it a popular choice for anesthesia and sedation procedures.
Researchers can optimize their Propofol studies by utilizing PubCompare.ai's AI-driven protocol comparison tool.
This powerful tool helps identify the most reproducible and accurate approaches from the literature, preprints, and patents, streamlining the research process.
PubCompare.ai's AI-powered insights provide invaluable guidance to ensure the highest levels of accuracy and reproducibility in Propofol research.
Propofol is chemically similar to other anesthetic agents like Diprivan, IsoFlo, and FBS (Forane), and researchers may also find DMSO (Dimethyl Sulfoxide) useful in Propofol-related studies.
By leveraging the insights and tools provided by PubCompare.ai, researchers can confidently navigate the wealth of Propofol-related information and protocols, ultimately enhancing the quality and efficiency of their Propofol-focused investigations.
It is commonly employed for the induction and maintenance of anesthesia, as well as for sedation in critical care settings and for the management of status epilepticus.
Propofol is prized for its rapid onset of action and short duration of effect, making it a popular choice for anesthesia and sedation procedures.
Researchers can optimize their Propofol studies by utilizing PubCompare.ai's AI-driven protocol comparison tool.
This powerful tool helps identify the most reproducible and accurate approaches from the literature, preprints, and patents, streamlining the research process.
PubCompare.ai's AI-powered insights provide invaluable guidance to ensure the highest levels of accuracy and reproducibility in Propofol research.
Propofol is chemically similar to other anesthetic agents like Diprivan, IsoFlo, and FBS (Forane), and researchers may also find DMSO (Dimethyl Sulfoxide) useful in Propofol-related studies.
By leveraging the insights and tools provided by PubCompare.ai, researchers can confidently navigate the wealth of Propofol-related information and protocols, ultimately enhancing the quality and efficiency of their Propofol-focused investigations.